Anion receptor-mediated multicomponent synergistic self-assembly of porphyrin for efficient phototherapy to elicit tumor immunotherapy. (October 2022)
- Record Type:
- Journal Article
- Title:
- Anion receptor-mediated multicomponent synergistic self-assembly of porphyrin for efficient phototherapy to elicit tumor immunotherapy. (October 2022)
- Main Title:
- Anion receptor-mediated multicomponent synergistic self-assembly of porphyrin for efficient phototherapy to elicit tumor immunotherapy
- Authors:
- Wang, Kui
Chen, Jie
Lin, Lin
Yan, Nan
Yang, Weihu
Cai, Kaiyong
Tian, Huayu
Chen, Xuesi - Abstract:
- Abstract: Immunogenic phototherapy has the potential to enhance tumor immunotherapy. Nevertheless, its efficacy is severely restricted by optimal photosensitizer deficiency and efficient delivery of the photosensitizers. We thus constructed TAPP-GCP@TCPP@BSA nanoparticles by self-assembling of a porphyrin derivative (TAPP-GCP), meso-tetra(4-carboxyphenyl) porphyrin (TCPP), and bovine serum albumin (BSA) to achieve effective phototherapy and further enhance tumor immunotherapy. Nanoparticles (NPs) subjected to laser irradiation can induce tumor cytotoxicity and immunogenic cell death (ICD). They can accumulate in tumors after intravenous injection and induce significant ICD after laser illumination, thereby promoting the maturation of antigen-presenting cells and activating the specific antitumor killing effect of cytotoxic T cells in a breast tumor model. NPs combined with anti-PD-L1 blockade significantly inhibited distant tumor growth by initiating an excellent antitumor immune response. The phototherapy of NPs through multicomponent synergistic self-assembly is a promising approach for boosting immune checkpoint blockade therapy. Graphical Abstract: Self-assembled novel nanostructured photosensitizers (TAPP-GCP@TCPP@BSA) can generate singlet oxygen and possess a good photothermal ability. Moreover, the nanophotosensitizers can elicit efficient tumor immunogenic cell death, which can remodel the tumor immunosuppressive microenvironment, and allows for integration withAbstract: Immunogenic phototherapy has the potential to enhance tumor immunotherapy. Nevertheless, its efficacy is severely restricted by optimal photosensitizer deficiency and efficient delivery of the photosensitizers. We thus constructed TAPP-GCP@TCPP@BSA nanoparticles by self-assembling of a porphyrin derivative (TAPP-GCP), meso-tetra(4-carboxyphenyl) porphyrin (TCPP), and bovine serum albumin (BSA) to achieve effective phototherapy and further enhance tumor immunotherapy. Nanoparticles (NPs) subjected to laser irradiation can induce tumor cytotoxicity and immunogenic cell death (ICD). They can accumulate in tumors after intravenous injection and induce significant ICD after laser illumination, thereby promoting the maturation of antigen-presenting cells and activating the specific antitumor killing effect of cytotoxic T cells in a breast tumor model. NPs combined with anti-PD-L1 blockade significantly inhibited distant tumor growth by initiating an excellent antitumor immune response. The phototherapy of NPs through multicomponent synergistic self-assembly is a promising approach for boosting immune checkpoint blockade therapy. Graphical Abstract: Self-assembled novel nanostructured photosensitizers (TAPP-GCP@TCPP@BSA) can generate singlet oxygen and possess a good photothermal ability. Moreover, the nanophotosensitizers can elicit efficient tumor immunogenic cell death, which can remodel the tumor immunosuppressive microenvironment, and allows for integration with checkpoint blockade therapy for the inhibition of distant tumor. ga1 Highlights: Nanophosensitizers was constructed by weak interaction, and phototherapy for tumor was achieved. The nanodrug exhibited multi-mode imaging, and induced immunogenetic cell death (ICD) for tumor cells. ICD strategy decreased the immune suppression and reversed the suppressive tumor microenvironment. The photo-immunotherapy strategy accomplished an efficient inhibition of distant tumor. … (more)
- Is Part Of:
- Nano today. Volume 46(2022)
- Journal:
- Nano today
- Issue:
- Volume 46(2022)
- Issue Display:
- Volume 46, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 46
- Issue:
- 2022
- Issue Sort Value:
- 2022-0046-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-10
- Subjects:
- Anion receptor -- Porphyrin -- Self-assembly -- Phototherapy -- Immunotherapy
Nanotechnology -- Periodicals
Nanosciences -- Périodiques
620.505 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17480132 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.nantod.2022.101579 ↗
- Languages:
- English
- ISSNs:
- 1748-0132
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6015.335517
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23983.xml